Versant Ventures is a venture capital firm primarily focused on biotechnology and life sciences, with a strong emphasis on novel therapeutics addressing unmet medical needs. Their strategy involves both investing in external companies and actively building new biotech startups through their in-house "Discovery Engines" across North America and Europe.
90% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $79.7M (across 21 rounds with reported amounts).
Portfolio
21
Fund Size
$5.5B
Top Stage
Series A
Last 12 Mo
2
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
21 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Gate Bioscience | Series B | $65M | Nov 2025 |
 Dualitas Therapeutics, Inc. | Series A | $65M | Sep 2025 |
 Helicore Biopharma Inc. | Series A | $65M | Jan 2025 |
 Antag Therapeutics | Series A | $80M | Dec 2024 |
| Gate Bioscience | Series A | $60M | Nov 2023 |
 Kate Therapeutics Inc. | Series A | $51M | Jun 2023 |
 Jnana Therapeutics | Series C | $107M | Nov 2022 |
 CODA Biotherapeutics | Series B | $28M | Dec 2021 |
| SSanReno Therapeutics | Unknown | $40M | Nov 2021 |
| BBright Peak Therapeutics | Series B | $107M | Jun 2021 |
 Capsida Biotherapeutics Inc. | Series A | $50M | Apr 2021 |
 Century Therapeutics | Series C | $160M | Mar 2021 |
| TT-knife GmbH | Series A | $66M | Aug 2020 |
 VectivBio | Unknown | $35M | Jan 2020 |
 Black Diamond Therapeutics | Series C | $85M | Dec 2019 |
| CChinook Therapeutics | Series A | $65M | Aug 2019 |
| Century Therapeutics | Unknown | $250M | Jul 2019 |
 Nuvaira | Series C | $79M | Feb 2019 |
 Akero Therapeutics | Series B | $70M | Dec 2018 |
 Aprea Therapeutics | Series C | $50M | Nov 2018 |
 Jade Biosciences | Unknown | $95M | — |
Top Co-Investors
RA Capital Management5 shared
OrbiMed3 shared
Redmile Group2 shared
Rock Springs Capital2 shared
Apple Tree Partners2 shared
Eli Lilly and Company2 shared
GV (Google Ventures)2 shared
ARCH Venture Partners2 shared
Samsara BioCapital2 shared
Westlake Village BioPartners2 shared
Qatar Investment Authority2 shared
Casdin Capital2 shared
Logos Capital2 shared
Leaps by Bayer2 shared
Invus2 shared
Alexandria Venture Investments2 shared
Wellington Management2 shared
Novo Holdings2 shared
Janus Henderson Investors1 shared
Cormorant Asset Management1 shared
Last updated: 12 April 2026